Related Experiment Video
Updated: Jul 10, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
Novel obesity treatments
Shohinee Sarma1, Susan Tran2, Michael Fralick2
1Institute of Health Policy, Management and Evaluation (Sarma, Fralick), University of Toronto, Toronto, Ont.; Division of Endocrinology, Diabetes and Metabolism (Sarma), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; Division of Endocrinology (Tran), Department of Medicine, Michael Garron Hospital, University of Toronto; Division of General Internal Medicine (Fralick), Sinai Health System, Toronto, Ont. ssarma@bidmc.harvard.edu.
No abstract available in PubMed .
Related Concept Videos
Obesity
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Antidepressant Drugs: MAOIs and Other Agents
Oral Hypoglycemic Agents: Biguanides and Glitazones
Regulation of Food Intake

